202 related articles for article (PubMed ID: 18751426)
21. FOXP3+ regulatory T cells affect the development and progression of hepatocarcinogenesis.
Kobayashi N; Hiraoka N; Yamagami W; Ojima H; Kanai Y; Kosuge T; Nakajima A; Hirohashi S
Clin Cancer Res; 2007 Feb; 13(3):902-11. PubMed ID: 17289884
[TBL] [Abstract][Full Text] [Related]
22. Enrichment of CCR6+Foxp3+ regulatory T cells in the tumor mass correlates with impaired CD8+ T cell function and poor prognosis of breast cancer.
Xu L; Xu W; Qiu S; Xiong S
Clin Immunol; 2010 Jun; 135(3):466-75. PubMed ID: 20181533
[TBL] [Abstract][Full Text] [Related]
23. Incidence and prognostic impact of FoxP3+ regulatory T cells in human gliomas.
Heimberger AB; Abou-Ghazal M; Reina-Ortiz C; Yang DS; Sun W; Qiao W; Hiraoka N; Fuller GN
Clin Cancer Res; 2008 Aug; 14(16):5166-72. PubMed ID: 18698034
[TBL] [Abstract][Full Text] [Related]
24. [Immunoregulatory role of 1, 25-dihydroxyvitamin D(3)-treated dendritic cells in allergic airway inflammation].
Xia JB; Wang CZ; Ma JX; An XJ
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(8):514-8. PubMed ID: 19567068
[TBL] [Abstract][Full Text] [Related]
25. Higher FoxP3 mRNA expression in peripheral blood mononuclear cells of GAD65 or IA-2 autoantibody-positive compared with autoantibody-negative persons.
Link M; Salur L; Kisand K; Rajasalu T; Tillmann V; Uibo R
APMIS; 2008 Oct; 116(10):896-902. PubMed ID: 19132983
[TBL] [Abstract][Full Text] [Related]
26. Changes in peripheral blood level of regulatory T cells in patients with malignant melanoma during treatment with dendritic cell vaccination and low-dose IL-2.
Bjoern J; Brimnes MK; Andersen MH; Thor Straten P; Svane IM
Scand J Immunol; 2011 Mar; 73(3):222-33. PubMed ID: 21204893
[TBL] [Abstract][Full Text] [Related]
27. The role of FoxP3+CD4+CD25hi Tregs in the pathogenesis of myasthenia gravis.
Zhang Y; Wang HB; Chi LJ; Wang WZ
Immunol Lett; 2009 Jan; 122(1):52-7. PubMed ID: 19111574
[TBL] [Abstract][Full Text] [Related]
28. In vitro suppression of xenoimmune-mediated macrophage activation by human CD4+CD25+ regulatory T cells.
Fu Y; Yi S; Wu J; Jimenez E; Simond D; Hawthorne WJ; O'Connell PJ
Transplantation; 2008 Sep; 86(6):865-74. PubMed ID: 18813112
[TBL] [Abstract][Full Text] [Related]
29. CD4CD25+ regulatory T cells in patients with advanced gastrointestinal cancer treated with chemotherapy.
Xu H; Mao Y; Dai Y; Wang Q; Zhang X
Onkologie; 2009 May; 32(5):246-52. PubMed ID: 19420970
[TBL] [Abstract][Full Text] [Related]
30. Autologous dendritic cells loaded with apoptotic tumor cells induce T cell-mediated immune responses against breast cancer in vitro.
Delirezh N; Moazzeni SM; Shokri F; Shokrgozar MA; Atri M; Kokhaei P
Cell Immunol; 2009; 257(1-2):23-31. PubMed ID: 19306994
[TBL] [Abstract][Full Text] [Related]
31. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J
Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
[TBL] [Abstract][Full Text] [Related]
32. The role of Foxp3+ regulatory T cells in kidney transplantation.
Karczewski M; Karczewski J; Kostrzewa A; Wiktorowicz K; Glyda M
Transplant Proc; 2009 Jun; 41(5):1527-9. PubMed ID: 19545671
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of a dysfunctional and short-lived subset of monocyte-derived dendritic cells from cancer patients.
Onishi H; Morisaki T; Kuroki H; Matsumoto K; Baba E; Kuga H; Tanaka M; Katano M
Anticancer Res; 2005; 25(5):3445-51. PubMed ID: 16101162
[TBL] [Abstract][Full Text] [Related]
34. A phase I-II study of alpha-galactosylceramide-pulsed IL-2/GM-CSF-cultured peripheral blood mononuclear cells in patients with advanced and recurrent non-small cell lung cancer.
Motohashi S; Nagato K; Kunii N; Yamamoto H; Yamasaki K; Okita K; Hanaoka H; Shimizu N; Suzuki M; Yoshino I; Taniguchi M; Fujisawa T; Nakayama T
J Immunol; 2009 Feb; 182(4):2492-501. PubMed ID: 19201905
[TBL] [Abstract][Full Text] [Related]
35. Study of liver-targeted regulatory T cells in hepatitis B and C virus in chronically infected patients.
Miyaaki H; Zhou H; Ichikawa T; Nakao K; Shibata H; Takeshita S; Akiyama M; Ozawa E; Miuma S; Eguchi K
Liver Int; 2009 May; 29(5):702-7. PubMed ID: 18673437
[TBL] [Abstract][Full Text] [Related]
36. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.
Kang N; Tang L; Li X; Wu D; Li W; Chen X; Cui L; Ba D; He W
Immunol Lett; 2009 Aug; 125(2):105-13. PubMed ID: 19539651
[TBL] [Abstract][Full Text] [Related]
37. Regulatory T-cells in periapical lesions.
Colić M; Gazivoda D; Vucević D; Majstorović I; Vasilijić S; Rudolf R; Brkić Z; Milosavljević P
J Dent Res; 2009 Nov; 88(11):997-1002. PubMed ID: 19828886
[TBL] [Abstract][Full Text] [Related]
38. Enhancement of anti-tumor immunity by high levels of Th1 and Th17 with a combination of dendritic cell fusion hybrids and regulatory T cell depletion in pancreatic cancer.
Yamamoto M; Kamigaki T; Yamashita K; Hori Y; Hasegawa H; Kuroda D; Moriyama H; Nagata M; Ku Y; Kuroda Y
Oncol Rep; 2009 Aug; 22(2):337-43. PubMed ID: 19578774
[TBL] [Abstract][Full Text] [Related]
39. Progressive divergent shifts in natural and induced T-regulatory cells signify the transition from undifferentiated to definitive connective tissue disease.
Szodoray P; Nakken B; Barath S; Gaal J; Aleksza M; Zeher M; Sipka S; Szilagyi A; Zold E; Szegedi G; Bodolay E
Int Immunol; 2008 Aug; 20(8):971-9. PubMed ID: 18550583
[TBL] [Abstract][Full Text] [Related]
40. B7-1 and B7-2 differentially control peripheral homeostasis of CD4(+)CD25(+)Foxp3(+) regulatory T cells.
Zeng M; Guinet E; Nouri-Shirazi M
Transpl Immunol; 2009 Jan; 20(3):171-9. PubMed ID: 18848987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
